TITLE

The totally drug resistant tuberculosis (TDR-TB)

AUTHOR(S)
Velayati, Ali Akbar; Farnia, Parissa; Masjedi, Mohammad Reza
PUB. DATE
May 2013
SOURCE
International Journal of Clinical & Experimental Medicine;2013, Vol. 6 Issue 4, p307
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented which discusses totally drug-resistant tuberculosis (TDR-TB) for TB strains which showed in-vitro resistance to all first and second line drugs tested including isoniazid, rifampicin, and cycloserine.
ACCESSION #
89082694

 

Related Articles

  • Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa. Rabna, Paulo; Ramos, Jorge; Ponce, Gema; Sanca, Lilica; Mané, Morto; Armada, Ana; Machado, Diana; Vieira, Fina; Gomes, Victor F.; Martins, Elisabete; Colombatti, Raffaella; Riccardi, Fabio; Perdigão, João; Sotero, Joana; Portugal, Isabel; Couto, Isabel; Atouguia, Jorge; Rodrigues, Amabélia; Viveiros, Miguel // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Background: This study aimed to evaluate the usefulness of the Xpert MTB/RIF assay for the rapid direct detection of M. tuberculosis complex (MTBC) strains and rifampicin resistance associated mutations in a resource-limited setting such as Guinea-Bissau and its implications in the management...

  • Yeni ve �nceden Tedavi Almis Akciger T�berk�lozlu Olgularda Ila� Diren�leri. K�m�rc�oglu, Berna; Senol, G�nes; Balci, G�nseli; Yalniz, Enver; �zden, Emel // Akciger Arsivi/Archives of Lung;Dec2007, Vol. 8 Issue 4, p117 

    Objective: This study was planned to determine the resistance rates against tuberculosis (TB) drugs in pulmonery tuberculosis patients in a ward of Izmir Chest Diseases and Surgery Researh Hospital. Data of 387 hospitalised male patients with active pulmonary tuberculosis between 1999-2004 were...

  • Genetic characterization of compensatory evolution in strains carrying rpoB Ser531Leu, the rifampicin resistance mutation most frequently found in clinical isolates. Brandis, Gerrit; Hughes, Diarmaid // Journal of Antimicrobial Chemotherapy (JAC);Nov2013, Vol. 68 Issue 11, p2493 

    Objectives The evolution of rifampicin resistance in Mycobacterium tuberculosis is a major threat to effective tuberculosis therapy. Much is known about the initial emergence of rifampicin resistance, but the further evolution of these resistant strains has only lately been subject to...

  • Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success. Daniels, Johnny Flippie; Khogali, Mohammed; Mohr, Erika; Cox, Vivian; Moyo, Sizulu; Edginton, Mary; Hinderaker, Sven Gudmund; Meintjes, Graeme; Hughes, Jennifer; De Azevedo, Virginia; van Cutsem, Gilles; Cox, Helen Suzanne // PLoS ONE;10/11/2015, Vol. 10 Issue 10, p1 

    Setting: Khayelitsha, South Africa, with high burdens of rifampicin-resistant tuberculosis (RR-TB) and HIV co-infection. Objective: To describe time to antiretroviral treatment (ART) initiation among HIV-infected RR-TB patients initiating RR-TB treatment and to assess the association between...

  • Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study. Berhanu, Rebecca; Schnippel, Kathryn; Mohr, Erika; Hirasen, Kamban; Evans, Denise; Rosen, Sydney; Sanne, Ian // PLoS ONE;11/3/2016, Vol. 11 Issue 11, p1 

    Objective: We describe baseline characteristics, time to treatment initiation and interim patient outcomes at a decentralized, outpatient treatment site for rifampicin-resistant TB (RR-TB). Methods: Prospective observational cohort study of RR-TB patients from March 2013 until December 2014....

  • Frequency of mutations in rifampicin and isoniazid resistant isolates of M. tuberculosis: an analysis from Central India. Desikan, Prabha; Kharate, Atul; Panwalkar, Nikita; Khurana, Jyoti; Mirza, Shaina Beg; Chaturvedi, Aparna; Varathe, Reeta; Chourey, Manju; Kumar, Pradeep; Doshi, Nitin; Pandey, Manoj // Germs;Dec2016, Vol. 6 Issue 4, p125 

    Background The spread of drug-resistant tuberculosis has challenged tuberculosis control strategies globally. The present study aims to analyzes the frequency of mutations in rpoB, katG and inhA genes in strains of M. tuberculosis complex (MTBC) circulating in Central India. It is anticipated...

  • Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis. Martin, Anandi; Paasch, Fabienne; Docx, Sven; Fissette, Krista; Imperiale, Belen; Ribón, Wellman; González, Liliana Andrea; Werngren, Jim; Engström, Anna; Skenders, Girts; Juréen, Pontus; Hoffner, Sven; Del Portillo, Patricia; Morcillo, Nora; Palomino, Juan Carlos // Journal of Antimicrobial Chemotherapy (JAC);Apr2011, Vol. 66 Issue 4, p827 

    Objectives To perform a multicentre study to evaluate the performance of the colorimetric redox indicator (CRI) assay and to establish the MICs and critical concentrations of rifampicin, isoniazid, ofloxacin, kanamycin and capreomycin. Methods The study was carried out in two phases. Phase I...

  • Treatment of LTBI -- Is INH It?  // Infectious Disease Alert;Feb2009, Vol. 28 Issue 5, p23 

    The article discusses the comparison between the drugs isoniazid (INH) and rifampin in terms of safety and effectiveness when used as treatment for latent tuberculosis infection (LTBI). It references a study by M. Menzies et al, published in the 2008 issue of the "Annals of Internal Medicine."...

  • Development of extended release matrices of rifampicin using hot melt extrusion technique. Sharma, Vanita J.; Amin, Purnima D. // Journal of Applied Pharmaceutical Science;Oct2013, Vol. 3 Issue 10, p30 

    Tuberculosis has metamorphosized over the decades from drug resistant to multidrug resistant to the lethal extensively drug resistant forms lately. With scarce newer anti-TB drugs emerging, there is a pressing need to ameliorate the current treatment therapy by modulating the formulation...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics